Qiagen Coverage Assumed by Jefferies at Buy Vs Previous Rating of Hold
Qiagen Analyst Ratings
Jefferies Initiates Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $54
UBS Maintains Qiagen NV(QGEN.US) With Hold Rating
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $45
Qiagen (QGEN) Receives a Hold From Stifel Nicolaus
TD Cowen Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $49
Deutsche Bank Maintains Qiagen NV(QGEN.US) With Buy Rating
HSBC Downgrades Qiagen NV(QGEN.US) to Hold Rating, Cuts Target Price to $49
Qiagen Analyst Ratings
BofA Securities Maintains Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $55
Berenberg Lifts Price Target on Qiagen to EUR54.90 From EUR54.20, Keeps Buy Rating
Qiagen Analyst Ratings
Qiagen (QGEN) Gets a Hold From UBS
BofA Securities Maintains Qiagen NV(QGEN.US) With Buy Rating
TD Cowen Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $51
Goldman Sachs Maintains Qiagen NV(QGEN.US) With Buy Rating
Qiagen Upgraded at Wolfe on Valuation Discount
Qiagen Analyst Ratings
Qiagen Analyst Ratings